Ledger.Open graph →
SEC Form D · filed September 15, 2021

Via Nova Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OAKLAND, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Joseph Jimenez · Philadelphia, PADirectorDonald Ganem · OAKLAND, CAExec · DirectorBenjamine Liu · OAKLAND, CADirectorIlan Zipkin · South San Francisco, CADirectorDonald Ganem · OAKLAND, CAExec · DirectorJoseph Jimenez · San Mateo, CADirectorBenjamine Liu · OAKLAND, CADirectorIlan Zipkin · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗